Correlation Between Nextedia and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nextedia and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nextedia and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nextedia and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Nextedia and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nextedia with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nextedia and Sartorius Stedim.

Diversification Opportunities for Nextedia and Sartorius Stedim

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nextedia and Sartorius is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Nextedia and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Nextedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nextedia are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Nextedia i.e., Nextedia and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Nextedia and Sartorius Stedim

Assuming the 90 days trading horizon Nextedia is expected to under-perform the Sartorius Stedim. In addition to that, Nextedia is 1.45 times more volatile than Sartorius Stedim Biotech. It trades about -0.07 of its total potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.02 per unit of volatility. If you would invest  18,400  in Sartorius Stedim Biotech on August 31, 2024 and sell it today you would lose (290.00) from holding Sartorius Stedim Biotech or give up 1.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nextedia  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Nextedia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nextedia has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Nextedia and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nextedia and Sartorius Stedim

The main advantage of trading using opposite Nextedia and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nextedia position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Nextedia and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.